Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pression sanguine And NotMichel Marre

List of bibliographic references

Number of relevant bibliographic references: 45.
Ident.Authors (with country if any)Title
000298 S. Zoungas [Australie] ; J. Chalmers [Australie] ; B. Neal [Australie] ; L. Billot [Australie] ; Q. Li [Australie] ; Y. Hirakawa [Australie] ; H. Arima [Australie] ; H. Monaghan [Australie] ; R. Joshi [Australie] ; S. Colagiuri [Australie] ; M. E. Cooper [Australie] ; P. Glasziou [Australie] ; D. Grobbee [Pays-Bas] ; P. Hamet [Canada] ; S. Harrap [Australie] ; S. Heller [Royaume-Uni] ; L. Lisheng [République populaire de Chine] ; G. Mancia [Italie] ; M. Marre [France] ; D. R. Matthews [Royaume-Uni] ; C. E. Mogensen [Danemark] ; V. Perkovic [Australie] ; N. Poulter [Royaume-Uni] ; A. Rodgers [Australie] ; B. Williams [Royaume-Uni] ; S. Macmahon [Australie, Royaume-Uni] ; A. Patel [Australie] ; M. Woodward [Australie, Royaume-Uni, États-Unis]Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
000901 Carla Canniffe [Irlande (pays)] ; Phalla Ou [France] ; Kevin Walsh [Irlande (pays)] ; Damien Bonnet [France] ; David Celermajer [Australie]Hypertension after repair of aortic coarctation - A systematic review
000B86 C. Delcourt [Australie] ; C. Stapf [France] ; C. Tzourio [France] ; S. Heritier [Australie] ; C. Anderson [Australie]La seconde phase d'une étude randomisée, multicentrique évaluant en ouvert l'effet de la réduction intensive de la pression artérielle dans l'hémorragie cérébrale (INTERACT2): protocole et caractéristiques des patients inclus en France
000C09 Patrick Rossignol [France] ; Joelle Cridlig [France] ; Philippe Lehert [Belgique, Australie] ; Michele Kessler [France] ; Faiez Zannad [France]Visit-to-Visit Blood Pressure Variability Is a Strong Predictor of Cardiovascular Events in Hemodialysis Insights From FOSIDIAL
001179 Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie, Royaume-Uni] ; Giuseppe Mancia [Italie] ; Marie-Germaine Bousser [France] ; Christophe Tzourio [France] ; Anthony Rodgers [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie]Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial
001577 Sébastien Czernichow [Australie, France] ; Alberto Zanchetti [Italie] ; Fiona Turnbull [Australie] ; Federica Barzi [Australie] ; Toshiaru Ninomiya [Australie] ; André-Pascal Kengne [Australie] ; Hiddo J. Lambers Heerspink [Pays-Bas] ; Vlado Perkovic [Australie] ; Rachel Huxley [Australie] ; Hisatomi Arima [Australie] ; Anushka Patel [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie]The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
001686 Jacqueline L. Webster [Australie] ; Elizabeth K. Dunford [Australie] ; Corinna Hawkes [France, Royaume-Uni] ; Bruce C. Neal [Australie]Salt reduction initiatives around the world
001763 RUI YANG [Belgique] ; Ilse Smolders [Belgique] ; Patrick Vanderheyden [Belgique] ; Heidi Demaegdt [Belgique] ; Ann Van Eeckhaut [Belgique] ; Georges Vauquelin [Belgique] ; Aneta Lukaszuk [Belgique] ; Dirk Tourwe [Belgique] ; Siew Yeen Chai [Australie] ; Anthony L. Albiston [Australie] ; Clara Nahmias [France] ; Thomas Walther [Royaume-Uni] ; Alain G. Dupont [Belgique, Allemagne]Pressor and Renal Hemodynamic Effects of the Novel Angiotensin A Peptide Are Angiotensin II Type 1A Receptor Dependent
001B53 David A. Calhoun [États-Unis] ; William B. White [États-Unis] ; Henry Krum [Australie] ; WEINONG GUO [États-Unis] ; Georgina Bermann [Suisse] ; Angelo Trapani [États-Unis] ; Martin P. Lefkowitz [États-Unis] ; Joel Menard [France]Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial
001B59 Andrei Cividjian [France] ; Emil Toader [France] ; Karel H. Wesseling [Pays-Bas] ; John M. Karemaker [Pays-Bas] ; Robin Mcallen [Australie] ; Luc Quintin [France]Effect of clonidine on cardiac baroreflex delay in humans and rats
001E05 Jasper J. Brugts [Pays-Bas] ; Aaron Isaacs [Pays-Bas] ; Moniek P. M. De Maat [Pays-Bas] ; Eric Boersma [Pays-Bas] ; Cock M. Van Duijn [Pays-Bas] ; K. Martijn Akkerhuis [Pays-Bas] ; Andre G. Uitterlinden [Pays-Bas] ; Jacqueline C. M. Witteman [Pays-Bas] ; Francois Cambien [France] ; Claudio Ceconi [Italie] ; Willem Remme [Pays-Bas] ; Michel Bertrand [France] ; Toshiharu Ninomiya [Australie] ; Stephen Harrap [Australie] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Kim Fox [Royaume-Uni] ; Roberto Ferrari [Italie] ; Maarten L. Simoons [Pays-Bas] ; A. H. Jan Danser [Pays-Bas]A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals
001E40 André-Pascal Kengne [Australie] ; Sébastien Czernichow [Australie, France] ; John Chalmers [Australie]Variables tensionnelles et risque cardiovasculaire chez les diabétiques de type 2 dans l'étude ADVANCE
001F73 L. Fezeu [France, Cameroun] ; A. P. Kengne [Cameroun, Australie] ; B. Balkau [France] ; P. K. Awah [Cameroun] ; J. C. Mbanya [Cameroun]Ten-year change in blood pressure levels and prevalence of hypertension in urban and rural Cameroon
002158 Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; LISHENG LIU [République populaire de Chine] ; Christophe Tzourio [France] ; Mark Woodward [États-Unis] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Anthony Rodgers [Australie] ; John Chalmers [Australie]Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
002329 Duncan J. Campbell [Australie] ; Habib Karam [France] ; Patrick Bruneval [France] ; John J. Mullins [Royaume-Uni] ; Joël Menard [France]Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease
002339 Sébastien Czernichow [Australie, France] ; Toshiharu Ninomiya [Australie] ; Rachel Huxley [Australie] ; André-Pascal Kengne [Australie] ; G. David Batty [Australie, Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie]Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial
002461 Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Craig Anderson [Australie] ; Mark Woodward [États-Unis] ; Marie-Germaine Bousser [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie]Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
002A23 Francesca Mastorci [Italie] ; Massimo Vicentini [Italie] ; Odile Viltart [France] ; Massimo Manghi [Italie] ; Gallia Graiani [Italie] ; Federico Quaini [Italie] ; Peter Meerlo [Pays-Bas] ; Eugene Nalivaiko [Australie] ; Stefania Maccari [France] ; Andrea Sgoifo [Italie]Long-term effects of prenatal stress : Changes in adult cardiovascular regulation and sensitivity to stress
002C39 B. E. De Galan [Australie, Pays-Bas] ; S. Zoungas [Australie] ; J. Chalmers [Australie] ; C. Anderson [Australie] ; C. Dufouil [France] ; A. Pillai [Australie] ; M. Cooper [Australie] ; D. E. Grobbee [Pays-Bas] ; M. Hackett [Australie] ; P. Hamet [Canada] ; S. R. Heller [Royaume-Uni] ; L. Lisheng [République populaire de Chine] ; S. Macmahon [Australie] ; G. Mancia [Italie] ; B. Neal [Australie] ; C. Y. Pan [République populaire de Chine] ; A. Patel [Australie] ; N. Poulter [Royaume-Uni] ; F. Travert [France] ; M. Woodward [Australie, États-Unis]Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
002C56 Ruth Peters [Royaume-Uni] ; Ruth Poulter [Royaume-Uni] ; Nigel Beckett [Royaume-Uni] ; Françoise Forette [France] ; Robert Fagard [Belgique] ; John Potter [Royaume-Uni] ; Cameron Swift [Royaume-Uni] ; Craig Anderson [Australie] ; Astrid Fletcher [Royaume-Uni] ; Christopher J. Bulpitt [Royaume-Uni]Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial
002C57 Claude Julien [France] ; Sandra L. Burke [Australie] ; Geoffrey A. Head [Australie]Cardiac and renal baroreflex control during stress in conscious renovascular hypertensive rabbits : effect of rilmenidine. Commentary
002C66 Andre-Pascal Kengne [Australie] ; Sébastien Czernichow [France] ; Rachel Huxley [Australie] ; Diederick Grobbee [Pays-Bas] ; Mark Woodward [États-Unis] ; Bruce Neal [Australie] ; Sophia Zoungas [Australie] ; Mark Cooper [Australie] ; Paul Glasziou [Royaume-Uni] ; Pavel Hamet [Canada] ; Stephen B. Harrap [Australie] ; Giuseppe Mancia [Italie] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; John Chalmers [Australie]Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE
003410 Sebastien Fuchs [États-Unis] ; Hong D. Xiao [États-Unis] ; Christine Hubert [France] ; Annie Michaud [France] ; Duncan J. Campbell [Australie] ; Jonathan W. Adams [États-Unis] ; Mario R. Capecchi [Australie] ; Pierre Corvol [France] ; Kenneth E. Bernstein [États-Unis]Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo
003775 Leopold Fezeu [France, Cameroun] ; Beverley Balkau [France] ; André-Pascal Kengne [Cameroun, Australie] ; Eugène Sobngwi [Cameroun] ; Jean-Claude Mbanya [Cameroun]Metabolic syndrome in a sub-Saharan African setting: Central obesity may be the key determinant
003A21 Paul Elliott [Royaume-Uni] ; Lesley L. Walker [Australie] ; Mark P. Little [Royaume-Uni] ; John R. Blair-West [Australie, États-Unis] ; Robert E. Shade [États-Unis] ; D. Rick Lee [États-Unis] ; Pierre Rouquet [Gabon] ; Eric Leroy [Gabon] ; Xavier Jeunemaitre [France] ; Raymond Ardaillou [France] ; Francoise Paillard [France] ; Pierre Meneton [France] ; Derek A. Denton [États-Unis, Australie]Change in salt intake affects blood pressure of chimpanzees : Implications for human populations
003A22 Enrico Agabiti-Rosei [Italie] ; Giuseppe Mancia [Italie] ; Michael F. O'Rourke [Australie] ; Mary J. Roman [États-Unis] ; Michel E. Safar [France] ; Harold Smulyan [États-Unis] ; Ji-Guang Wang [République populaire de Chine] ; Ian B. Wilkinson [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; Charalambos Vlachopoulos [Grèce]Central blood pressure measurements and antihypertensive therapy : A consensus document
003A25 Philippe Gosse [France] ; Georgios Papaioanou [France] ; Paul Coulon [France] ; Sylvain Reuter [France] ; Philippe Lemetayer [France] ; Michel Safar [France] ; Michael F. O'Rourke [Australie]Can ambulatory blood-pressure monitoring provide reliable indices of arterial stiffness?
003D31 John Chalmers [Australie] ; Nikola Sprigg [Royaume-Uni] ; Laura J. Gray [Royaume-Uni] ; Philip M. W. Bath [Royaume-Uni] ; Gudrun Boysen [Danemark] ; Peter Paul De Deyn [Belgique] ; Pal Friis [Norvège] ; Didier Leys [France] ; Reijo Marttila [Finlande] ; Jan-Edwin Olsson [Suède] ; Desmond O'Neill [Irlande (pays)] ; Bernd Ringelstein [Allemagne] ; Jan-Jacob Van Der Sande [Pays-Bas] ; Ewa Lindenstr M [Danemark]Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke : data from the TAIST trial. Commentary
003D55 F. Zannad [France] ; M. Kessler [France] ; P. Lehert [Australie, Belgique] ; J. P. Grünfeld [France] ; C. Thuilliez [France] ; A. Leizorovicz [France] ; P. Lechat [France]Prevention of cardiovascular events in end-stage renal disease : Results of a randomized trial of fosinopril and implications for future studies
003F04 Hisatomi Arima [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Craig Anderson [Australie] ; Anthony Rodgers [Nouvelle-Zélande] ; Stephen Davis [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie]Lower target blood pressures are safe and effective for the prevention of recurrent stroke : the PROGRESS trial
004183 Carlene M. M. Lawes [Nouvelle-Zélande] ; Stephen Vander Hoorn [Nouvelle-Zélande] ; Malcolm R. Law [Royaume-Uni] ; Paul Elliott [Royaume-Uni] ; Stephen Macmahon [Australie] ; Anthony Rodgers [Nouvelle-Zélande] ; Francois Gueyffier [France] ; James Wright [Canada]Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. Commentary
004199 Phalla Ou [France] ; Elie Mousseaux [France] ; David S. Celermajer [Australie] ; Elisa Pedroni [France] ; Pascal Vouhe [France] ; Daniel Sidi [France] ; Damien Bonnet [France]Aortic arch shape deformation after coarctation surgery : Effect on blood pressure response
004439 Rodolphe Thiebaut [France] ; Wafaa M. El-Sadr [États-Unis] ; Nina Friis-M Ller [Danemark] ; Martin Rickenbach [Suisse] ; Peter Reiss [Pays-Bas] ; Antonella D'Arminio Monforte [Italie] ; Linda Morfeldt [Suède] ; Eric Fontas [France] ; Ole Kirk [Danemark] ; Stephane De Wit [Belgique] ; Gonzalo Calvo [Espagne] ; Matthew G. Law [Australie] ; Francois Dabis [France] ; Caroline A. Sabin [Royaume-Uni] ; Jens D. Lundgren [Danemark]Predictors of hypertension and changes of blood pressure in HIV-infected patients
004640 Carole Dufouil [France] ; John Chalmers [Australie] ; Oguzhan Coskun [France] ; Véronique Besancon [France] ; Marie-Germaine Bousser [France] ; Pierre Guillon [France] ; Stephen Macmahon [Australie] ; Bernard Mazoyer [France] ; Bruce Neal [Australie] ; Mark Woodward [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Christophe Tzourio [France, Australie]Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) magnetic resonance imaging substudy
004648 Rainer Oberbauer [Autriche] ; Giuseppe Segoloni [Italie] ; Josep M. Campistol [Espagne] ; Henri Kreis [France] ; Alfredo Mota [Portugal] ; Joseph Lawen [Canada] ; Graeme Russ [Australie] ; Josep M. Grinyo [Espagne] ; Giovanni Stallone [Italie] ; Anders Hartmann [Norvège] ; Jose R. Pinto [Portugal] ; Jeremy Chapman [Australie] ; James T. Burke [France] ; Yves Brault [France] ; John F. Neylan [États-Unis]Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation
004950 Angel Argiles [France, Australie] ; Ronan Lorho ; Marie-Francoise Servel ; Guillaume Chong ; Peter G. Kerr ; Georges MouradSeasonal modifications in blood pressure are mainly related to interdialytic body weight gain in dialysis patients
004A68 Gérard M. London [France] ; Roland G. Asmar [France] ; Michaël F. O'Rourke [Australie] ; Michel E. Safar [France]Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: Comparison with atenolol
004B06 Jean L. Rouleau [Canada] ; Ellen B. Roecker [États-Unis] ; Michal Tendera [Pologne] ; Paul Mohacsi [Suisse] ; Henry Krum [Australie] ; Hugo A. Katus [Allemagne] ; Michael B. Fowler [États-Unis] ; Andrew J. S. Coats [Australie] ; Alain Castaigne [France] ; Armin Scherhag [Suisse] ; Terly L. Holcslaw [États-Unis] ; Milton Packer [États-Unis] ; Jay N. Cohn [États-Unis]Influence of pretreatment systolic blood pressure on the effect of Carvedilol in patients with severe chronic heart failure: The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. Author's reply
004B08 Jane E. Butler [États-Unis, Australie] ; Edith Ribot-Ciscar [France] ; Inge Zijdewind [Pays-Bas] ; Christine K. Thomas [États-Unis]Increased blood pressure can reduce fatigue of thenar muscles paralyzed after spinal cord injury
005368 Christine Vayssettes-Courchay [France] ; Francoise Bouysset [France] ; Tony J. Verbeuren [France]Involvement of COX and NOS induction in the sympatho-activation during sepsis
005703 Robert W. G. Johnson [Royaume-Uni] ; Henri Kreis [France] ; Rainer Oberbauer [Autriche] ; Christina Brattström [Suède] ; Kerstin Claesson [Suède] ; Josette Eris [Australie]Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure
005967 Céline Fassot [France] ; Elisabeth Lambert [Australie] ; Gavin Lambert [Australie] ; Peter Friberg [Suède] ; Jean-Luc Elghozi [France]Acute and chronic alterations in blood pressure variability following experimental subarachnoid haemorrhage
005C60 Cécile Dufour [France] ; Didier Casane [France] ; Derek Denton [Australie] ; Jean Wickings [Gabon] ; Pierre Corvol [France] ; Xavier Jeunemaitre [France]Human-chimpanzee DNA sequence variation in the four major genes of the renin angiotensin system
006442 J. Feldman [France] ; H. Greney [France] ; L. Monassier [France] ; C. Vonthron [France] ; V. Bruban [France] ; M. Dontenwill [France] ; P. Bousquet [France]Does a second generation of centrally acting antihypertensive drugs really exist?
006800 N. Niederhoffer [France] ; Yu. V. Bobryshev [Australie] ; I. Lartaud-Idjouadiene [France] ; P. Giummelly [France] ; J. Atkinson [France]Aortic calcification produced by vitamin D3 plus nicotine

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024